A rice cracker manufacturer and a pharmaceutical company have jointly developed a new product, "Kameda no Kaki no Tane,"
the first ever
functional food product in the history of Kaki no Tane, focusing on the theme of "health."
It contains globin peptide *1, which helps suppress the rise in triglycerides after meals.
March 9, 2023
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Ibaraki City, Osaka Prefecture, President and Representative Director: Yasuo Sumida), a subsidiary of MG Pharma Inc., Ltd. (Headquarters: Osaka City, Osaka Prefecture, President and Representative Director: Masafumi Sugimoto), has collaborated with Kameda Seika Co., Ltd. (Headquarters: Niigata City, Niigata Prefecture, President and Representative Director: Masaki Takagi) to develop "57g Kameda Kaki no Tane for those concerned about post-meal triglycerides" (hereinafter: "Kameda Kaki no Tane for those concerned about post-meal triglycerides"), the first functional food product in the history of the Kaki no Tane genre*2. It will be released sequentially from March 14th (Tuesday) at select Seven-Eleven stores for a limited time and in limited regions.
*1: "Globin peptide (METAP®)" is a peptide mixture containing the valine-valine-tyrosine-proline (VVYP) tetrapeptide, which has been shown to have the effect of suppressing the rise in triglycerides.
*2: According to Kameda Seika Co., Ltd. (March 2023)
Background of product development
Kameda Seika Co., Ltd., as a leading domestic rice cracker manufacturer, has provided joy and enrichment to customers' lives from the perspective of "Better For You." Meanwhile, MG Pharma Inc. has contributed to people's health by developing the "NAPPLE" series of functional foods, including a Food for Specified Health Uses (FOSHU) for managing triglycerides containing the original ingredient "Globin Peptide (METAP®)."
In today's rapidly changing health landscape, the Healthy Item Report indicates that an average of 24.1% of people across all age groups are concerned about their triglycerides. Broken down by age, over 20% of both men and women in their 40s are concerned about triglycerides, and approximately one in three people in their 50s and 60s are concerned about their triglycerides*3. As customers aged 40 and over overlap with the purchasing demographic of "Kameda no Kaki no Tane," we aim to contribute to extending healthy life expectancy and have decided to launch "Kameda no Kaki no Tane for those concerned about post-meal triglycerides," a functional food product containing Rohto Pharmaceutical Group's MG Pharma's original ingredient, "Globin Peptide (METAP®)."
*3: Healthy Item Report 2020
Product overview
|
 |
| Product name |
57g Kameda Kaki no Tane (rice crackers) - For those concerned about post-meal triglyceride levels. |
| release date |
Starting sequentially from Tuesday, March 14, 2023 |
| Price (excluding tax) |
138円 |
| Sales area |
Tokyo, Chiba, Kanagawa, Saitama, Niigata, Fukui, Ishikawa, Toyama |
| Sales channels |
Seven-Eleven stores in the above areas |
*Please note that some stores in the above-mentioned regions may not carry this product.
Foods with functional claims
Notification Statement: This product contains globin-derived valine-valine-tyrosine-proline. Globin-derived valine-valine-tyrosine-proline has been reported to suppress the rise in postprandial blood triglycerides by inhibiting the absorption of dietary fat.
*Maintain a balanced diet based on staple foods, main dishes, and side dishes.
*This product has been registered with the Commissioner of the Consumer Affairs Agency as a product that is expected to have a specific health purpose under the responsibility of the business operator. However, unlike Foods for Specified Health Uses, it has not undergone individual review by the Commissioner of the Consumer Affairs Agency.
*This product is not intended for the diagnosis, treatment, or prevention of disease.
* "Metap" is a registered trademark of MG Pharma Inc.
*
is a registered trademark of MG Pharma Inc.
About Metap
Metap is a peptide mixture developed by MG Pharma Inc. after more than 30 years of research. The "valine-valine-tyrosine-proline (VVYP) tetrapeptide" within Metap has been found to have strong activity in suppressing the rise in triglycerides after meals.
"Effects of globin-derived valine-valine-tyrosine-proline (human trials)"
*One research paper that was selected for review is presented as an example.